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Available online 20 November 20131. Introduction pediatric allergists. Children whose anaphylaxis diagnosisAnaphylaxis involves several organ systems and evolves
dynamically, that is, it may spontaneously stop with mild
symptoms or rapidly progress to life-threatening laryngeal
edemaor shock. It is not possible to determine the severity of
the attack in advance. Severe anaphylaxis deserves special
attention because of its increased risk of morbidity and
mortality. Although not asmuchas anaphylaxis in general,1e3
reports of severe anaphylaxis have been increasing in num-
ber with time. For this reason our study aimed to investigate
the demographics, atopic status, etiological factors, clinical
properties, treatment, and follow-up of patients who pre-
sented with severe anaphylaxis.
2. Methods
We conducted a retrospective medical chart review for a
10-year period between January 2002 and September 2012.
The patients’ files were separately reviewed by two* Corresponding author. Department of Pediatric Allergy and
Asthma, Gazi University Faculty of Medicine, 06510 Bes‚evler,
Ankara, Turkey.
E-mail address: erdemtopal44@gmail.com (E. Topal).
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criteria for severe anaphylaxis according to the position
paper of the European Academy of Allergology and Clinical
Immunology4 were included in the final analysis. De-
mographics, triggers, number of previous anaphylaxis epi-
sodes, clinical manifestations and involved systems, the
interval between exposure and the onset of anaphylaxis,
treatment of the acute episode, comorbid diseases, and
long-term management were recorded. Etiologic factors
were determined by history and skin prick and/or intrader-
mal tests with the suspected allergens mentioned in the
history.
The study was approved by the Ethics Committee of Gazi
University, Ankara, Turkey.
3. Results
During a period of 10 years in the Gazi University Pediatric
Allergy and Asthma Department, 34 (25%) of 136 cases were
diagnosed as severe anaphylaxis. Twenty-one of these
patients were male (61.8%), and the mean age was
79.0  61.7 months. Drugs were the most common etio-
logical agents (61.8%; Table 1) . In six cases (17.6%) there
was a comorbidity of atopic disease (3 asthma cases, 2
allergic rhinitis cases, and 2 atopic eczema cases). Fiveed by Elsevier Taiwan LLC. All rights reserved.
Severe anaphylaxis in children 321cases had a history of type 1 food allergy, four cases had a
history of type 1 drug allergy, and four cases had an
anaphylaxis attack previously (foods were the etiological
agents in all previous attacks of anaphylaxis). The analysis
of the reported interval between exposure to the causative
agent and the appearance of the first symptom showed that
in 20 cases (58.8%) the reaction was immediate
(1e5 minutes), in eight cases (23.5%) the reaction within
5e30 minutes, and in six cases (17.6%) the reaction was
within 30e120 minutes. Respiratory symptoms (25 cases,
73.5%) were the most common symptoms observed, fol-
lowed by cardiovascular and cutaneous symptoms (23
cases, 67.6%; Table 1). Hypotension was detected in 21 of
25 patients whose blood pressure was measured. Five casesTable 1 Causes, symptoms, and signs of severe anaphy-
laxis (n Z 34).
n (%) Specific agent (n)
Causative agent
Drugs 21 (61.8) Antibiotics (11)
Cephalosporins (6)
Penicillin (4)
Vancomycin (1)
NSAIDs (3)
Enzyme replacement
therapy (3)
a-L-iduronate (1)
Idursulfase (1)
Galsulfase (1)
General anesthetic
agents (3)
Insulin (1)
Food 6 (17.6) Hen’s egg (3)
Cow’s milk (2)
Peach (1)
Venom 6 (17.6) Vespids (4)
Aphids (2)
Exercise-induced 1 (2.9)
Symptom or sign
Respiratory 25 (73.5)
Dyspnea 6 (17.6)
Stridor 12 (35.3)
Wheezing 2 (5.9)
Cough 6 (17.6)
Rhinorrhea 2 (5.9)
Hoarseness 2 (5.9)
Cyanosis 17 (50)
Cardiovascular 23 (67.6)
Hypotension 21/25 (84)*
Syncope 17 (50)
Arrest 5 (14.7)
Cutaneous 23 (67.6)
Angioedema 17 (50)
Urticaria 18 (52.9)
Flushing 6 (17.6)
Pruritus 4 (11.8)
Gastrointestinal 4 (11.8)
Persistent vomiting 4 (11.8)
NSAIDs Z non-steroidal anti-inflammatory drugs.
* Only 25 of the cases whose blood pressure was measured.(14.7%) had a cardiac arrest. Twelve cases (35.2%) had
stridor, 17 cases (50%) had cyanosis, and 17 cases (50%) had
syncope. The youngest patient who had a cardiac arrest
was 30 months old and the oldest patient was 72 months
old. All were male, and the reaction occurred within the
first 5 minutes after exposure. The etiological agent was
ceftriaxone in three cases, penicillin in one case, and a
general anesthetic agent in one case. Detailed information
was available in three cases that had cardiac arrest. Two
patients responded to cardiopulmonary resuscitation within
5 minutes (etiological agents were ceftriaxone in one case
and general anesthetic agent in the other case). The other
case was treated with cardiopulmonary resuscitation for
15 minutes, had been intubated, and taken to the intensive
care unit (etiological drug was ceftriaxone). After this
event, the child recovered but had neurological problems.
Treatment of anaphylaxis in the medical facility for those
30 cases whose medical records have been accessed
included antihistamines in 26 patients (86.6%), corticoste-
roids in 27 patients (90%), epinephrine in 20 patients
(66.6%), oxygen in 28 patients (93.3%), IV fluid in 23 pa-
tients (76.6%), and a b-2 agonist in five patients (16.6%).
Four patients (11.7%) needed IM adrenaline twice. Six pa-
tients (17.6%) were observed in the emergency room for
more than 24 hours, five patients (14.7%) were followed up
in the intensive care unit, and two patients were hospi-
talized for underlying systemic disease. Thirteen of 34
cases were prescribed an epinephrine autoinjector: six for
food (46.1%), six for hymenoptera venom (46.1%), and one
for exercise-induced (7.8%) anaphylaxis. Thirty-two pa-
tients could be contacted for follow-up. Two had experi-
enced a second episode after diagnosis (6.2%). Although an
epinephrine autoinjector was prescribed and patients/
parents were trained in their use previously, only one of
them had used the epinephrine self-administration device
(Epipen) at the time of the reaction.4. Discussion
This study showed that drugs were the major etiological
factor in severe anaphylaxis cases, and symptoms and signs
occurred immediately after contact with the suspicious
agent. Although the most frequent symptoms/signs involved
were respiratory, hypotension was detected in a remarkable
percentage of patients with severe ana-phylaxis.
In retrospective studies of anaphylaxis cases, cutaneous
symptoms/signs were the most common during the reac-
tion. Respiratory and cardiovascular symptoms were
generally observed less often than cutaneous symptoms/
signs.1e3 However, Stoevesandt et al5 reported that the
absence of urticaria and angioedema was frequently asso-
ciated with venom-induced severe anaphylaxis. In our
study, respiratory symptoms/signs were most prominent in
cases of severe anaphylaxis. Cardiovascular and cutaneous
symptoms/signs followed respiratory symptoms/signs. Also,
more than 80% of our patients were reported to be hypo-
tensive, which is an important sign. It shows the severity of
the reaction and is an alarming signal for morbidity and
mortality from anaphylaxis. Renaudin et al6 analyzed 333
cases who were diagnosed with drug-induced severe
anaphylaxis. Among those, 76.6% had anaphylactic shock.
322 E. Topal et alThese results illustrate that hypotension is a common
finding in severe anaphylaxis.
Pumphrey7 studied the average time from contact with
the trigger to onset of cardiopulmonary arrest in severe
anaphylaxis that resulted in death. This time was reported
to be 30 minutes in food-induced, 15 minutes in venom-
induced, and 5 minutes in drug-induced anaphylaxis.
Stoevesandt et al5 found a significant association between
the onset of the reaction and the severity of venom-
induced anaphylaxis, that is, if the reaction starts within
the first 5 minutes, the episode is more severe. In our study,
two-thirds of patients with severe anaphylaxis had re-
actions that developed within the first 5 minutes.
Failure to measure serum tryptase level in patients
diagnosed with severe anaphylaxis is a limitation of this
study. It has been shown that a high serum tryptase level is
a risk factor in severe anaphylaxis.5 Moreover, the small
number of patients and the retrospective nature of the
study are additional limitations.
In conclusion, drugs are the major triggers of severe
anaphylaxis. The reaction occurs immediately after contact
with the etiological factor. The most frequent symptoms/
signs involve the respiratory system followed by the car-
diovascular system and cutaneous.
Conflicts of interest
The authors have no conflicts of interest relevant to this
article.References
1. Orhan F, Canitez Y, Bakirtas A, Yilmaz O, Boz AB, Can D, et al.
Anaphylaxis in Turkish children: a multi-centre, retrospective,
case study. Clin Exp Allergy 2011;41:1767e76.
2. De Swert LF, Bullens D, Raes M, Dermaux AM. Anaphylaxis in
referred pediatric patients: demographic and clinical features,
triggers, and therapeutic approach. Eur J Pediatr 2008;167:
1251e61.
3. Rudders SA, Banerji A, Clark S, Camargo Jr CA. Age-related
differences in the clinical presentation of food-induced
anaphylaxis. J Pediatr 2011;158:326e8.
4. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G,
et al. The management of anaphylaxis in childhood: position
paper of the European Academy of Allergology and Clinical
Immunology. Allergy 2007;62:857e71.
5. Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and under-
estimated parameters in severe hymenoptera venom-induced
anaphylaxis: cardiovascular medication and absence of urticar-
ia/angioedema. J Allergy Clin Immunol 2012;130:698e704.
6. Renaudin JM, Beaudouin E, Ponvert C, Demoly P, Moneret-
Vautrin DA. Severe drug-induced anaphylaxis: analysis of 333
cases recorded by the Allergy Vigilance Network from 2002 to
2010. Allergy 2013;68:929e37.
7. Pumphrey RS. Lessons for management of anaphylaxis from a
study of fatal reactions. Clin Exp Allergy 2000;30:1144e50.
